These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs. Haider MZ, Rasoul MA, Al-Mahdi M, Al-Kandari H, Dhaunsi GS. PLoS One; 2018; 13(6):e0198652. PubMed ID: 29924845 [Abstract] [Full Text] [Related]
5. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Bjørnvold M, Undlien DE, Joner G, Dahl-Jørgensen K, Njølstad PR, Akselsen HE, Gervin K, Rønningen KS, Stene LC. Diabetologia; 2008 Apr; 51(4):589-96. PubMed ID: 18292987 [Abstract] [Full Text] [Related]
7. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Achenbach P, Hummel M, Thümer L, Boerschmann H, Höfelmann D, Ziegler AG. Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116 [Abstract] [Full Text] [Related]
8. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). Butty V, Campbell C, Mathis D, Benoist C, DPT-1 Study Group. Diabetes; 2008 Sep; 57(9):2348-59. PubMed ID: 18556337 [Abstract] [Full Text] [Related]
9. The effect of childhood cow's milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young. Lamb MM, Miller M, Seifert JA, Frederiksen B, Kroehl M, Rewers M, Norris JM. Pediatr Diabetes; 2015 Feb; 16(1):31-8. PubMed ID: 24444005 [Abstract] [Full Text] [Related]
10. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity. Hermann R, Laine AP, Veijola R, Vahlberg T, Simell S, Lähde J, Simell O, Knip M, Ilonen J. Diabetologia; 2005 Sep; 48(9):1766-75. PubMed ID: 16025255 [Abstract] [Full Text] [Related]
11. rs11203203 is associated with type 1 diabetes risk in population pre-screened for high-risk HLA-DR,DQ genotypes. Johnson K, Wong R, Barriga KJ, Klingensmith G, Ziegler AG, Rewers MJ, Steck AK. Pediatr Diabetes; 2012 Dec; 13(8):611-5. PubMed ID: 22776074 [Abstract] [Full Text] [Related]
12. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity. Mikk ML, Pfeiffer S, Kiviniemi M, Laine AP, Lempainen J, Härkönen T, Toppari J, Veijola R, Knip M, Ilonen J, Finnish Pediatric Diabetes Register. Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719 [Abstract] [Full Text] [Related]
13. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity. Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd JA, Ziegler AG, Bonifacio E. Diabetologia; 2003 May; 46(5):712-20. PubMed ID: 12750767 [Abstract] [Full Text] [Related]
14. Association of non-HLA genes with type 1 diabetes autoimmunity. Steck AK, Bugawan TL, Valdes AM, Emery LM, Blair A, Norris JM, Redondo MJ, Babu SR, Erlich HA, Eisenbarth GS, Rewers MJ. Diabetes; 2005 Aug; 54(8):2482-6. PubMed ID: 16046318 [Abstract] [Full Text] [Related]
15. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases? Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U. Diabetes Metab Res Rev; 2000 Aug; 16(1):8-14. PubMed ID: 10707033 [Abstract] [Full Text] [Related]
16. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O, Knip M, Ilonen J. Diabetologia; 2006 Jun; 49(6):1198-208. PubMed ID: 16614815 [Abstract] [Full Text] [Related]
17. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. Aly TA, Ide A, Humphrey K, Barker JM, Steck A, Erlich HA, Yu L, Miao D, Redondo MJ, McFann K, Roberts CM, Babu SR, Norris JM, Eisenbarth GS, Rewers MJ. J Autoimmun; 2005 Jun; 25 Suppl():40-5. PubMed ID: 16242305 [Abstract] [Full Text] [Related]
18. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children. Ziegler AG, Pflueger M, Winkler C, Achenbach P, Akolkar B, Krischer JP, Bonifacio E. J Autoimmun; 2011 Aug; 37(1):3-7. PubMed ID: 21376535 [Abstract] [Full Text] [Related]
19. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group. Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R. Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055 [Abstract] [Full Text] [Related]
20. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany. Kordonouri O, Hartmann R, Charpentier N, Knip M, Danne T, Ilonen J. Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847 [Abstract] [Full Text] [Related] Page: [Next] [New Search]